Genetron Holdings (GTH) Financial Statements
Price: $4.025
Market Cap: $127.29M
Avg Volume: 51.86K
Market Cap: $127.29M
Avg Volume: 51.86K
Country: CN
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Genetron Holdings.
Income Statement
Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
---|---|---|---|---|---|---|
Revenue | $650.71M | $531.95M | $424.49M | $323.43M | $225.18M | $101.03M |
Cost of Revenue | $369.28M | $193.98M | $164.27M | $178.44M | $132.45M | $74.21M |
Gross Profit | $281.43M | $337.97M | $260.22M | $144.99M | $92.73M | $26.82M |
Gross Profit Ratio | 43.25% | 63.53% | 61.30% | 44.83% | 41.18% | 26.55% |
Research and Development Expenses | $290.29M | $253.95M | $149.00M | $91.70M | $71.41M | $45.78M |
General and Administrative Expenses | $266.91M | $227.00M | $126.32M | $117.17M | $88.23M | $45.49M |
Selling and Marketing Expenses | $364.56M | $343.16M | $246.96M | $253.56M | $182.47M | $94.57M |
Selling General and Administrative Expenses | $631.47M | $570.16M | $373.28M | $370.73M | $270.71M | $140.06M |
Other Expenses | $-8.71M | $-5.33M | $-8.53M | $-10.85M | $-233.63M | $-258.11M |
Operating Expenses | $913.05M | $818.78M | $513.75M | $451.58M | $332.19M | $181.01M |
Cost and Expenses | $1.28B | $1.01B | $678.02M | $630.01M | $464.64M | $255.22M |
Interest Income | $2.86M | $20.50M | $28.33M | $441.00K | $1.55M | $513.00K |
Interest Expense | $111.48M | $5.25M | $5.63M | $5.40M | $- | $669.00K |
Depreciation and Amortization | $85.39M | $20.50M | $-2.80B | $-319.22M | $27.86M | $20.61M |
EBITDA | $-546.24M | $-460.31M | $-3.05B | $-625.81M | $-443.69M | $-401.17M |
EBITDA Ratio | -83.94% | -86.53% | -718.18% | -193.49% | -197.04% | -397.06% |
Operating Income | $-631.62M | $-480.82M | $-253.53M | $-306.59M | $-232.98M | $-152.54M |
Operating Income Ratio | -97.07% | -90.39% | -59.73% | -94.79% | -103.46% | -150.98% |
Total Other Income Expenses Net | $-179.01M | $-21.78M | $-2.82B | $-369.44M | $-227.08M | $-256.30M |
Income Before Tax | $-810.63M | $-502.60M | $-3.07B | $-676.03M | $-464.99M | $-420.64M |
Income Before Tax Ratio | -124.58% | -94.48% | -723.00% | -209.02% | -206.50% | -416.34% |
Income Tax Expense | $73.26M | $-64.19M | $-2.87B | $-354.54M | $-232.02M | $-257.44M |
Net Income | $-883.89M | $-438.40M | $-198.10M | $-321.49M | $-464.99M | $-420.64M |
Net Income Ratio | -135.84% | -82.41% | -46.67% | -99.40% | -206.50% | -416.34% |
EPS | $-9.53 | $-4.76 | $-3.29 | $-4.65 | $-6.73 | $-6.22 |
EPS Diluted | $-9.53 | $-4.76 | $-3.29 | $-4.65 | $-6.73 | $-6.22 |
Weighted Average Shares Outstanding | 92.80M | 92.11M | 60.28M | 69.07M | 69.07M | 67.68M |
Weighted Average Shares Outstanding Diluted | 92.80M | 92.11M | 60.28M | 69.07M | 69.07M | 67.68M |
SEC Filing | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
---|---|---|---|---|---|---|
Cash and Cash Equivalents | $176.27M | $639.04M | $1.38B | $139.95M | $62.13M | $42.03M |
Short Term Investments | $157.43M | $151.44M | $140.29M | $122.22M | $38.60M | $252.91M |
Cash and Short Term Investments | $333.69M | $790.49M | $1.52B | $262.18M | $100.72M | $294.94M |
Net Receivables | $323.36M | $388.38M | $208.34M | $105.37M | $70.86M | $33.86M |
Inventory | $42.43M | $35.60M | $24.97M | $17.90M | $21.61M | $12.77M |
Other Current Assets | $9.47M | $30.70M | $36.50M | $43.71M | $37.49M | $25.80M |
Total Current Assets | $708.95M | $1.25B | $1.79B | $429.15M | $230.69M | $367.37M |
Property Plant Equipment Net | $177.64M | $162.36M | $136.60M | $126.19M | $82.55M | $65.30M |
Goodwill | $- | $- | $- | $- | $- | $- |
Intangible Assets | $32.07M | $20.70M | $12.27M | $5.48M | $3.40M | $3.88M |
Goodwill and Intangible Assets | $32.07M | $20.70M | $12.27M | $5.48M | $3.40M | $3.88M |
Long Term Investments | $50.50M | $49.78M | $19.61M | $- | $- | $- |
Tax Assets | $- | $- | $- | $- | $- | $- |
Other Non-Current Assets | $6.17M | $37.61M | $15.36M | $12.68M | $7.80M | $4.90M |
Total Non-Current Assets | $266.37M | $270.44M | $183.83M | $144.36M | $93.75M | $74.09M |
Other Assets | $- | $- | $- | $- | $- | $- |
Total Assets | $975.33M | $1.52B | $1.97B | $573.51M | $324.44M | $441.46M |
Account Payables | $63.05M | $55.77M | $34.07M | $49.95M | $11.90M | $8.85M |
Short Term Debt | $131.22M | $40.13M | $75.17M | $34.88M | $929.00K | $- |
Tax Payables | $3.04M | $2.58M | $1.67M | $4.63M | $929.00K | $706.00K |
Deferred Revenue | $22.04M | $11.96M | $8.42M | $18.19M | $8.87M | $3.40M |
Other Current Liabilities | $173.56M | $157.24M | $111.19M | $109.72M | $46.08M | $33.38M |
Total Current Liabilities | $389.87M | $265.09M | $228.84M | $212.74M | $67.77M | $45.63M |
Long Term Debt | $27.34M | $33.87M | $48.51M | $32.77M | $- | $- |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $9.76M | $8.61M | $- | $2.11B | $1.32B | $1.02B |
Total Non-Current Liabilities | $37.10M | $42.48M | $48.51M | $2.14B | $1.32B | $1.02B |
Other Liabilities | $- | $- | $- | $- | $- | $- |
Total Liabilities | $426.97M | $307.57M | $277.35M | $2.35B | $1.39B | $1.06B |
Preferred Stock | $- | $- | $- | $- | $- | $- |
Common Stock | $61.00K | $61.00K | $59.00K | $17.00K | $- | $- |
Retained Earnings | $-6.25B | $-5.44B | $-4.94B | $-1.84B | $-1.17B | $-702.95M |
Accumulated Other Comprehensive Income Loss | $56.17M | $-69.09M | $-24.70M | $69.21M | $112.26M | $91.54M |
Other Total Stockholders Equity | $6.73B | $6.71B | $6.66B | $-3.58M | $-8.36M | $-10.77M |
Total Stockholders Equity | $546.12M | $1.21B | $1.69B | $-1.78B | $-1.06B | $-622.19M |
Total Equity | $548.36M | $1.21B | $1.69B | $-1.78B | $-1.06B | $-622.19M |
Total Liabilities and Stockholders Equity | $975.33M | $1.52B | $1.97B | $573.51M | $324.44M | $441.46M |
Minority Interest | $2.23M | $4.46M | $- | $- | $- | $- |
Total Liabilities and Total Equity | $975.33M | $1.52B | $1.97B | $573.51M | $324.44M | $441.46M |
Total Investments | $207.92M | $201.22M | $159.90M | $122.22M | $38.60M | $252.91M |
Total Debt | $158.57M | $73.99M | $123.68M | $67.64M | $- | $- |
Net Debt | $-17.70M | $-565.05M | $-1.25B | $-72.31M | $-62.13M | $-42.03M |
Cash Flow Statement
Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
---|---|---|---|---|---|---|
Net Income | $-810.63M | $-502.60M | $-3.07B | $-676.03M | $-464.99M | $-420.64M |
Depreciation and Amortization | $77.42M | $63.09M | $53.20M | $46.59M | $27.86M | $20.61M |
Deferred Income Tax | $- | $31.33M | $2.83B | $360.22M | $-6.49M | $256.46M |
Stock Based Compensation | $17.49M | $54.14M | $29.95M | $35.88M | $29.64M | $20.70M |
Change in Working Capital | $73.89M | $-151.67M | $-124.57M | $26.96M | $-20.60M | $-17.56M |
Accounts Receivables | $-10.57M | $-153.94M | $-95.72M | $-48.15M | $-27.41M | $-6.92M |
Inventory | $-6.82M | $-10.63M | $-7.08M | $3.72M | $-8.85M | $-9.22M |
Accounts Payables | $13.73M | $23.58M | $-9.07M | $26.63M | $2.94M | $1.85M |
Other Working Capital | $77.56M | $-10.67M | $-12.71M | $44.76M | $12.72M | $-3.25M |
Other Non Cash Items | $181.62M | $-18.43M | $-24.79M | $9.42M | $233.56M | $10.51M |
Net Cash Provided by Operating Activities | $-460.20M | $-524.14M | $-300.90M | $-196.96M | $-201.02M | $-129.92M |
Investments in Property Plant and Equipment | $-82.14M | $-85.89M | $-50.03M | $-25.58M | $-47.42M | $-21.33M |
Acquisitions Net | $- | $2.00M | $-13.37M | $679.00K | $3.52M | $2.17M |
Purchases of Investments | $-1.24B | $-2.10B | $-1.73B | $-479.10M | $-895.14M | $-890.02M |
Sales Maturities of Investments | $1.24B | $2.06B | $1.70B | $396.42M | $1.12B | $713.36M |
Other Investing Activities | $3.00M | $-10.57M | $13.08M | $10.78M | $-6.07M | $-2.17M |
Net Cash Used for Investing Activities | $-87.83M | $-136.28M | $-84.65M | $-96.81M | $171.49M | $-197.99M |
Debt Repayment | $-54.92M | $-90.81M | $-40.28M | $-57.08M | $- | $-21.00M |
Common Stock Issued | $- | $- | $1.68B | $18.00K | $- | $2.17M |
Common Stock Repurchased | $- | $- | $-4.10M | $-54.48M | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $126.29M | $32.41M | $168.35M | $545.84M | $49.40M | $370.33M |
Net Cash Used Provided by Financing Activities | $71.37M | $-58.41M | $1.74B | $371.73M | $49.40M | $351.50M |
Effect of Forex Changes on Cash | $13.89M | $-17.90M | $-123.15M | $-139.00K | $223.00K | $78.00K |
Net Change in Cash | $-462.78M | $-736.72M | $1.24B | $77.83M | $20.10M | $23.67M |
Cash at End of Period | $176.27M | $639.04M | $1.38B | $139.95M | $62.13M | $42.03M |
Cash at Beginning of Period | $639.04M | $1.38B | $139.95M | $62.13M | $42.03M | $18.36M |
Operating Cash Flow | $-460.20M | $-524.14M | $-300.90M | $-196.96M | $-201.02M | $-129.92M |
Capital Expenditure | $-82.14M | $-85.89M | $-50.03M | $-25.58M | $-47.42M | $-21.33M |
Free Cash Flow | $-542.34M | $-610.04M | $-350.92M | $-222.54M | $-248.44M | $-151.25M |